吉林治疗尿道炎到哪家医院好吉林夜间尿频是怎么回事,吉林韩式包皮医院,吉林看阳痿手术哪个医院安全,吉林最好的男子医院是哪家,吉林医院阴茎长疙瘩不疼不痒,吉林长寿看前列腺哪家医院好,吉林做包皮包茎去哪家医院好点

BEIJING, May 16 (Xinhuanet) -- NASA is close to deciding on a landing site for its Mars rover Curiosity mission by narrowing the choices to four, media reports said Monday.Scientists in the close-knit Mars research community get one last chance to make their case this week when they gather before the "judges" — the team running the 2.5 billion U.S. dollar mission that will soon suggest a landing site to NASA, the ultimate decider."All four of these places are compelling places on Mars to study. There's not a loser among them," said landing site scientist Matt Golombek of the NASA Jet Propulsion Laboratory, one of the meeting's leaders.The mission will use rover Curiosity to study whether a selected area will have environmental conditions suitable for life and for preserving evidence about whether extraterrestial life has existed.Being nuclear-powered, the rover cannot go to a location that has either water or ice within one meter of the surface.The size of a mini Cooper, Curiosity is scheduled to launch in late November after a two-year delay.

BEIJING, Feb. 19 (Xinhua) -- As the traditional Spring Festival season ended two days ago, a new wave of post-holiday travel rush came to China's railway system, the Ministry of Railways (MOR) said Saturday.According to a statement from the MOR, the nation's railways carried 6.49 million passengers on Friday, the first day after the Lantern Festival which ended the festival season.The new wave of passengers mainly included students going back to school for the new semester and migrant workers returning to cities to start work. On Friday alone, 919,000 student passenger trips were made on railways, said the MOR.The ministry expected the travel volume and duration of the new peak to be similar to the previous year, with an average of more than 6 million railway passenger trips a daily.The MOR figures also showed that 166 million trips were made on railways since the Spring Festival travel rush began on Jan. 19, up 6 percent from the same period last year.

BEIJING, May 12 (Xinhuanet) -- Italian archaeologists are digging the remains of Lisa Gherardini, a 16th-century woman who is widely believed to be the model for the famous portrait Mona Lisa, AFP reported on Wednesday.The team of historians say they will try to find the remains using geo-radar equipment and then try to re-create a likeness of what the woman, Lisa Gherardini, would have looked like to compare her to Leonardo Da Vinci's Mona Lisa.Gherardini (1479-1542), also known by her married name as Lisa del Giocondo, was the wife of a Florentine silk merchant and is widely believed to have been the model for the  portrait that now hangs in the Louvre in Paris.But the issue has never been settled definitively and mystery still shrouds the model's enigmatic expression and other details of the portrait.

SAN FRANCISCO, March 21 (Xinhua) -- Microsoft on Monday sued Barnes & Noble, claiming patent infringement by the largest book retailer in the United States.Microsoft said it filed legal actions on Monday in both the U.S. International Trade Commission and the U.S. District Court of the Western District of Washington against Barnes & Noble, as well as Foxconn and Inventec, two manufacturers of Barnes & Noble's devices.According to Microsoft, the actions focus on the patent infringement by Barnes & Noble's Nook e-reader and tablet, both of which run Google's Android operating system.The patents at issue cover a range of functionality embodied in Android devices that are essential to the user experience, including natural ways of interacting with devices by tabbing through various screens to find the information they need, surfing the Web more quickly and interacting with documents and e-books, Microsoft said in a press release."The Android platform infringes a number of Microsoft's patents, and companies manufacturing and shipping Android devices must respect our intellectual property rights," Horacio Gutierrez, Microsoft's corporate vice president and deputy general counsel, was quoted by the press release as saying.Writing in a separate company blog post, Gutierrez said that the latest actions bring to 25 the total number of Microsoft patents in litigation for infringement by Android smartphones, tablets and other devices.He noted that Microsoft has established a licensing program to address Android's ongoing infringement, and leading Android smartphone manufacturer HTC has taken a license under this program.Amazon.com also signed a patent license with Microsoft last year covering its Kindle e-reader, he added."Unfortunately, after more than a year of discussions, Barnes & Noble, Foxconn and Inventec have so far been unwilling to sign a license, and therefore, we have no other choice but to bring legal action to defend our innovations," Gutierrez said in the blog post.

WASHINGTON, April 13 (Xinhua) -- The U.S. Food and Drug Administration (FDA) announced on Wednesday that it has approved the cPAX Aneurysm Treatment System for surgery on brain aneurysms that are difficult to manage because of their size and shape.An aneurysm is a bulge in the wall of a blood vessel, which can rupture as it increases in size, causing hemorrhage or death. Brain aneurysms often produce no symptoms until they grow and press on nerves in the brain, or until they begin to leak blood or rupture.Aneurysms can be repaired in two ways: surgeons can close the base of the aneurysm with a surgical clip, or use a technique commonly known as coiling, in which surgeons use a catheter to thread metallic coils through a blood vessel in the groin and into the blood vessel in the brain that contains the aneurysm. Surgeons then fill the aneurysm with the detachable coils, which block it from circulation and cause blood to clot, effectively destroying the aneurysm.Aneurysms larger than 10 millimeters are difficult to treat with clipping or coiling. The cPAX device system is indicated for use in those brain aneurysms."Like coiling, the cPAX Aneurysm Treatment System is a form of endovascular repair," said Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health. "But instead of tiny metallic coils, it uses a special polymer material to fill the space within the aneurysm."According to the FDA, the cPAX device system is indicated for use in adults aged 22 and older and should not be used in patients with an active infection or in those in whom anticoagulation and antiplatelet therapy is contraindicated.